AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3863847 — intervention group
Group type: COMPARATOR
Intervention: Waxed dental floss
Number of subjects: 34
Study 30030005 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal interphalangeal joint‐blocking orthosis (PIPJ‐BO)
Number of subjects: 35
Study 30030005 — intervention group
Group type: COMPARATOR
Intervention: Metacarpophalangeal joint‐blocking orthosis (MCPJ‐BO)
Number of subjects: 35
Study 29384848 — intervention group
Group type: EXPERIMENTAL
Intervention: Short‐cycle therapy (SCT)
Number of subjects: 199
Study 29384848 — intervention group
Group type: COMPARATOR
Intervention: Continuous therapy
Number of subjects: 199
Study 27499054 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer counselling about LARC with routine contraceptive counselling
Number of subjects: 110
Study 27499054 — intervention group
Group type: COMPARATOR
Intervention: Routine counselling alone
Number of subjects: 110
Study 25456803 — intervention group
Group type: EXPERIMENTAL
Intervention: School garden intervention
Number of subjects: 227
Study 25456803 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 227
Study 22516666 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine (150 mg daily)
Number of subjects: 54
Study 22516666 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (200 mg daily)
Number of subjects: 54
Study 22516666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 20801178 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft luncheon meat
Number of subjects: 106
Study 20801178 — intervention group
Group type: COMPARATOR
Intervention: Hard luncheon meat
Number of subjects: 106
Study 20801178 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum intake
Number of subjects: 106
Study 20801178 — intervention group
Group type: EXPERIMENTAL
Intervention: Texture differences
Number of subjects: 106
Study 19102944 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO (15,000 U/d)
Number of subjects: 72
Study 19102944 — intervention group
Group type: COMPARATOR
Intervention: rhIL-11 (3 mg/d)
Number of subjects: 72
Study 15718048 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-[18F]fluoro-L-dopa (Fdopa) PET scan
Number of subjects: 21
Study 15718048 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological test battery (VIG and Stroop tests)
Number of subjects: 21
Study 15718048 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 21
Study 12841801 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-administered detailed questionnaires, tailored education regarding medication use, help with appointment referrals, and creation of a summary of adherence barriers and medication discrepancies.
Number of subjects: 0
Study 12841801 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 10663363 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg/day
Number of subjects: 1226
Study 10663363 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 2.5 mg/day
Number of subjects: 1226
Study 10663363 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1226
Study 8863082 — intervention group
Group type: EXPERIMENTAL
Intervention: Violence Prevention Curriculum for Adolescents
Number of subjects: 225
Study 8863082 — intervention group
Group type: COMPARATOR
Intervention: Conflict Resolution: A Curriculum for Youth Providers
Number of subjects: 225
Study 8863082 — intervention group
Group type: EXPERIMENTAL
Intervention: Both curricula
Number of subjects: 225
Study 1446212 — intervention group
Group type: EXPERIMENTAL
Intervention: Words presented to the right visual field (RVF)
Number of subjects: 0
Study 1446212 — intervention group
Group type: EXPERIMENTAL
Intervention: Words presented to the left visual field (LVF)
Number of subjects: 0
Study 1446212 — intervention group
Group type: EXPERIMENTAL
Intervention: Pairs of nouns with close semantic associations
Number of subjects: 0
Study 1446212 — intervention group
Group type: EXPERIMENTAL
Intervention: Pairs of nouns with distant semantic associations
Number of subjects: 0
Study 1446212 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomly matched pairs of nouns
Number of subjects: 0
Study 3081082 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography of the thorax
Number of subjects: 300
Study 30332407 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality perspective-taking task
Number of subjects: 0
Study 30332407 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional perspective-taking task
Number of subjects: 0
Study 30332407 — intervention group
Group type: EXPERIMENTAL
Intervention: Desktop computer perspective-taking task
Number of subjects: 0
Study 30332407 — intervention group
Group type: COMPARATOR
Intervention: Control condition (fact-driven information about the homeless)
Number of subjects: 0
Study 30332407 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional and less immersive conditions
Number of subjects: 0
Study 27150916 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg of Tranexamic Acid (TXA) daily until complete radiological resolution of the CSDH or for a maximum of 20 weeks
Number of subjects: 130
Study 27150916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 27150916 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg of Tranexamic Acid (TXA) daily
Number of subjects: 130
Study 24329965 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative transfusion
Number of subjects: 70
Study 24329965 — intervention group
Group type: COMPARATOR
Intervention: No preoperative transfusion
Number of subjects: 70
Study 22832811 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized postoperative laxative protocol (n=19) including sterculia and frangula bark (Normacol Plus) and liquid paraffin (Agarol); second-line treatment with Movicol.
Number of subjects: 45
Study 22832811 — intervention group
Group type: COMPARATOR
Intervention: Ad hoc laxative intervention(s) as preferred by the surgical team (n=26).
Number of subjects: 45
Study 21045097 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall Prevention Tool Kit (FPTK)
Number of subjects: 10264
Study 21045097 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 10264
Study 15679463 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrant test (physical examination procedure)
Number of subjects: 74
Study 15679463 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral flexion (physical examination procedure)
Number of subjects: 74
Study 15679463 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-extremity weakness (physical examination procedure)
Number of subjects: 74
Study 15679463 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar extension (physical examination procedure)
Number of subjects: 74
Study 15679463 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (no lumbar PE procedure)
Number of subjects: 74
Study 14682645 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer cement
Number of subjects: 81
Study 14682645 — intervention group
Group type: COMPARATOR
Intervention: Zinc oxide-eugenol (ZOE) cement
Number of subjects: 81
Study 14682645 — intervention group
Group type: COMPARATOR
Intervention: Composite
Number of subjects: 81
Study 10754353 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic pacemaker function (Capturecontrol)
Number of subjects: 14
Study 10754353 — intervention group
Group type: COMPARATOR
Intervention: Manual pacing threshold measurement
Number of subjects: 14
Study 7611757 — intervention group
Group type: EXPERIMENTAL
Intervention: 5'-DFUR (oral administration at a mean dose of 10.0 g)
Number of subjects: 0
Study 7611757 — intervention group
Group type: COMPARATOR
Intervention: Control (no 5'-DFUR)
Number of subjects: 0
Study 7611757 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (5'-DFUR and Control)
Number of subjects: 0
Study 2122498 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive discharge planning protocol specific to the elderly implemented by a gerontological nurse specialist
Number of subjects: 280
Study 2122498 — intervention group
Group type: COMPARATOR
Intervention: Routine discharge planning
Number of subjects: 280
Study 598366 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedalling rate varied from 40 to 100 rpm at constant work load.
Number of subjects: 0
Study 598366 — intervention group
Group type: EXPERIMENTAL
Intervention: Work load varied from 2.5 to 10 mkp/s (patients) and 5 to 20 mkp/s (normals).
Number of subjects: 0
Study 30811141 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% lotion
Number of subjects: 909
Study 30811141 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 909
Study 28604179 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg lidocaine
Number of subjects: 100
Study 28604179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 26222347 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block (TAPB) with 15 mL of 0.5% ropivacaine per side
Number of subjects: 22
Study 26222347 — intervention group
Group type: COMPARATOR
Intervention: Rectus sheath block (RSB) with 15 mL of 0.5% ropivacaine per side
Number of subjects: 22
Study 24239202 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1002
Study 24239202 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 1002
Study 21150627 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-aided ipsilateral-dominant block using 6 ml of lidocaine 1.5%
Number of subjects: 24
Study 21150627 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled epidural analgesia using ropivacaine 0.2%
Number of subjects: 24
Study 21150627 — intervention group
Group type: COMPARATOR
Intervention: Midline approach for epidural puncture
Number of subjects: 24
Study 18639297 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine extended release plus tamsulosin
Number of subjects: 0
Study 18639297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18639297 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine extended release (4 mg)
Number of subjects: 0
Study 18639297 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg)
Number of subjects: 0
Study 16828595 — intervention group
Group type: EXPERIMENTAL
Intervention: Azimilide 125 mg once daily
Number of subjects: 220
Study 16828595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 16828595 — intervention group
Group type: EXPERIMENTAL
Intervention: Azimilide
Number of subjects: 220
Study 12616662 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral thrombin inhibitor LB-30057 (CI-1028)
Number of subjects: 0
Study 12616662 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct addition of LB-30057 to blood
Number of subjects: 0
Study 12616662 — intervention group
Group type: EXPERIMENTAL
Intervention: Coagulation tests
Number of subjects: 0
Study 10837293 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sucrose meal with 200 mg [13C]fructose
Number of subjects: 7
Study 10837293 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sucrose meal with 200 mg [13C]glucose
Number of subjects: 7
Study 10837293 — intervention group
Group type: COMPARATOR
Intervention: High-starch meal with 200 mg [13C]glucose
Number of subjects: 7
Study 9265198 — intervention group
Group type: EXPERIMENTAL
Intervention: Feldenkrais Method 'Awareness through Movement'
Number of subjects: 15
Study 9265198 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Feldenkrais course)
Number of subjects: 15
Study 8255966 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-testing for post-prandial glycosuria
Number of subjects: 13495
Study 8255966 — intervention group
Group type: COMPARATOR
Intervention: Fasting plasma glucose of 6 mmol/l
Number of subjects: 13495
Study 8255966 — intervention group
Group type: COMPARATOR
Intervention: Normal population control group (442 subjects from Ely)
Number of subjects: 13495
Study 2880459 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 60
Study 2880459 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 60
Study 2880459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30087174 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional PD solution
Number of subjects: 165
Study 30087174 — intervention group
Group type: COMPARATOR
Intervention: Biocompatible PD solution
Number of subjects: 165
Study 30087174 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal glucose exposure
Number of subjects: 165
Study 30087174 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal glucose degradation product content
Number of subjects: 165
Study 26813527 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (800 kcal) for 8 weeks
Number of subjects: 667
Study 25495811 — intervention group
Group type: EXPERIMENTAL
Intervention: Perhexiline
Number of subjects: 0
Study 25495811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22921262 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection
Number of subjects: 30
Study 22921262 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline injection
Number of subjects: 30
Study 20529406 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall dietary diversity
Number of subjects: 3245
Study 20529406 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-food group dietary diversity (especially in bread and cereals, vegetables, dairy products, and spreadable fats)
Number of subjects: 3245
Study 20529406 — intervention group
Group type: EXPERIMENTAL
Intervention: Diversity within the dairy and spreadable fat group
Number of subjects: 3245
Study 20529406 — intervention group
Group type: EXPERIMENTAL
Intervention: Diversity within the meat and energy-dense, nutrient-poor food groups
Number of subjects: 3245
Study 18177776 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (n=28)
Number of subjects: 86
Study 18177776 — intervention group
Group type: COMPARATOR
Intervention: Risperidone (n=29)
Number of subjects: 86
Study 18177776 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=29)
Number of subjects: 86
Study 15649235 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty (PTCA)
Number of subjects: 72
Study 15649235 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic therapy
Number of subjects: 72
Study 11900290 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 33
Study 11900290 — intervention group
Group type: EXPERIMENTAL
Intervention: ibutilide
Number of subjects: 33
Study 11900290 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 33
Study 10333900 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 19
Study 10333900 — intervention group
Group type: COMPARATOR
Intervention: Sulfonylurea
Number of subjects: 19
Study 8837958 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME (NO synthase inhibitor) at doses of 40 micrograms/kg injected plus 50 micrograms/kg infused i.v.
Number of subjects: 7
Study 8837958 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 7
Study 1978880 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 20
Study 1978880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6987113 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine (100 to 200 mg)
Number of subjects: 0
Study 6987113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30904596 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Tobacco Quitline
Number of subjects: 0
Study 30904596 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized Tobacco Quitline
Number of subjects: 0
Study 30904596 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Tobacco Quitline with Basic Needs Navigation
Number of subjects: 0
Study 30904596 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized Tobacco Quitline with Basic Needs Navigation
Number of subjects: 0
Study 30072407 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention aiming to improve the quality of dietary fat and promote intake of vegetables, fruits, and whole-grain products, with biannual counseling based on Nordic Nutrition Recommendations.
Number of subjects: 941
Study 26840437 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum (AL) hydration protocol
Number of subjects: 13
Study 26840437 — intervention group
Group type: COMPARATOR
Intervention: Individualized rehydration (IR) hydration protocol
Number of subjects: 13
Study 25173064 — intervention group
Group type: EXPERIMENTAL
Intervention: Four new healthy snack products (fruit, vegetables, bread, dip, topping)
Number of subjects: 600
Study 25173064 — intervention group
Group type: EXPERIMENTAL
Intervention: Health consciousness
Number of subjects: 600
Study 25173064 — intervention group
Group type: EXPERIMENTAL
Intervention: Snack neophobia
Number of subjects: 600
Study 25173064 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer influence
Number of subjects: 600
Study 25173064 — intervention group
Group type: EXPERIMENTAL
Intervention: Social activities
Number of subjects: 600
Study 25173064 — intervention group
Group type: EXPERIMENTAL
Intervention: Word-of-mouth
Number of subjects: 600
Study 22879630 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg daily for 3 months
Number of subjects: 40
Study 22879630 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 40
Study 22879630 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin followed by metformin 1500 mg daily
Number of subjects: 40
Study 21159599 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet Doctor website
Number of subjects: 714
Study 17397460 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen alone (5 mg kg(‐1))
Number of subjects: 201
Study 17397460 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol and ibuprofen combination (15/5 mg kg(‐1))
Number of subjects: 201
Study 17397460 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose paracetamol (20 mg kg(‐1))
Number of subjects: 201
Study 17397460 — intervention group
Group type: COMPARATOR
Intervention: Usual-dose paracetamol (15 mg kg(‐1))
Number of subjects: 201
Study 15721993 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-gestagen combination drug (17beta-estradiol+norethisterone acetate) with antipsychotic drug
Number of subjects: 46
Study 15721993 — intervention group
Group type: COMPARATOR
Intervention: Placebo with antipsychotic drug
Number of subjects: 46
Study 12010380 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth-dispersible aspirin 900 mg
Number of subjects: 101
Study 12010380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 9447289 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (MMI) 15 mg once daily (group S)
Number of subjects: 112
Study 9447289 — intervention group
Group type: COMPARATOR
Intervention: Methimazole (MMI) 10 mg 3 times daily (group C)
Number of subjects: 112
Study 9447289 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (C and S)
Number of subjects: 112
Study 8170855 — intervention group
Group type: EXPERIMENTAL
Intervention: Griseofulvin
Number of subjects: 30
Study 8170855 — intervention group
Group type: EXPERIMENTAL
Intervention: Griseofulvin plus erythromycin
Number of subjects: 30
Study 8170855 — intervention group
Group type: EXPERIMENTAL
Intervention: Griseofulvin plus prednisone
Number of subjects: 30
Study 8170855 — intervention group
Group type: EXPERIMENTAL
Intervention: Griseofulvin, erythromycin, and prednisone
Number of subjects: 30
Study 3063268 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 80 mg/d
Number of subjects: 58
Study 3063268 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol 1 g/d
Number of subjects: 58
Study 30143475 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed exercise regimen
Number of subjects: 85
Study 30143475 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-interactive exercise regimen
Number of subjects: 85
Study 30143475 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85
Study 26787644 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise oral misoprostol (50µg followed by two doses of 100µg)
Number of subjects: 0
Study 26787644 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol (three doses of 25µg inserted at intervals of 4h)
Number of subjects: 0
Study 26787644 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (oral and vaginal misoprostol)
Number of subjects: 0
Study 24584583 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low-Calorie-Ketogenic (VLCK) diet
Number of subjects: 0
Study 24584583 — intervention group
Group type: COMPARATOR
Intervention: Standard Low-Calorie (LC) diet
Number of subjects: 0
Study 22773672 — intervention group
Group type: EXPERIMENTAL
Intervention: Face mask
Number of subjects: 42
Study 22773672 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse chin cup
Number of subjects: 42
Study 20353551 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity (LPA)
Number of subjects: 84
Study 20353551 — intervention group
Group type: COMPARATOR
Intervention: FM education control (FME)
Number of subjects: 84
Study 18769081 — intervention group
Group type: EXPERIMENTAL
Intervention: ANP removed after 2 hours (Group II)
Number of subjects: 74
Study 18769081 — intervention group
Group type: COMPARATOR
Intervention: ANP removed after 24 to 48 hours (Group I)
Number of subjects: 74
Study 15715624 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (7.5 microg kg(‐1). h(‐1))
Number of subjects: 45
Study 15715624 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (30 microg kg(‐1). h(‐1))
Number of subjects: 45
Study 15715624 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 45
Study 15715624 — intervention group
Group type: EXPERIMENTAL
Intervention: All remifentanil groups
Number of subjects: 45
Study 15003430 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine XR (75-225 mg/day)
Number of subjects: 318
Study 15003430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 318
Study 11938826 — intervention group
Group type: EXPERIMENTAL
Intervention: Yixin Yidu Decoction (YXYDD)
Number of subjects: 76